Thromboembolic Complications of Stent-Assisted Coiling for Intracranial Aneurysms: A Single-Center Experience

C. Hong, Yeongu Chung, Y. Won, M. Rho, P. Chung
{"title":"Thromboembolic Complications of Stent-Assisted Coiling for Intracranial Aneurysms: A Single-Center Experience","authors":"C. Hong, Yeongu Chung, Y. Won, M. Rho, P. Chung","doi":"10.21129/nerve.2019.5.2.65","DOIUrl":null,"url":null,"abstract":"Corresponding author: Yu Sam Won Department of Neurosurgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29, Saemunan-ro, Jongno-gu, Seoul 03181, Republic of Korea Tel: +82-2-2001-2159 Fax: +82-2-2001-2157 E-mail: yusam.won@samsung.com Objective: Thromboembolism is the most common complication in stent-assisted coiling (SAC) procedures. This study aimed to evaluate the incidence and risk factors of thromboembolic complication in patients who underwent SAC for intracerebral aneurysm. Methods: Between January 2006 and December 2017, 35 patients (35 aneurysms) in the acute phase of subarachnoid hemorrhage (SAH) underwent SAC without antiplatelet premedication. Additionally, 45 patients (48 unruptured aneurysms) underwent SAC with antiplatelet premedication. Baseline patient characteristics were compared between the unruptured and ruptured aneurysm groups. Risk factors of thromboembolic complications were also analyzed. Results: Thromboembolic complications occurred in 11 of 83 aneurysms treated with SAC, among which 3 occurred in 48 unruptured aneurysms (6.3%; p=0.046) and 8 occurred in 35 ruptured aneurysms (22.9%; p=0.046). However, there was no permanent morbidity due to thromboembolic complications in either group. Conclusion: The thromboembolic complication rate for SAC in patients with ruptured aneurysms was significantly higher than for those with unruptured aneurysms. However, there was no permanent morbidity of thromboembolic complications, there seems to be no reason to reluctant SAC due to the risk of thromboembolic complications in patients with SAH.","PeriodicalId":229172,"journal":{"name":"The Nerve","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Nerve","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21129/nerve.2019.5.2.65","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Corresponding author: Yu Sam Won Department of Neurosurgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29, Saemunan-ro, Jongno-gu, Seoul 03181, Republic of Korea Tel: +82-2-2001-2159 Fax: +82-2-2001-2157 E-mail: yusam.won@samsung.com Objective: Thromboembolism is the most common complication in stent-assisted coiling (SAC) procedures. This study aimed to evaluate the incidence and risk factors of thromboembolic complication in patients who underwent SAC for intracerebral aneurysm. Methods: Between January 2006 and December 2017, 35 patients (35 aneurysms) in the acute phase of subarachnoid hemorrhage (SAH) underwent SAC without antiplatelet premedication. Additionally, 45 patients (48 unruptured aneurysms) underwent SAC with antiplatelet premedication. Baseline patient characteristics were compared between the unruptured and ruptured aneurysm groups. Risk factors of thromboembolic complications were also analyzed. Results: Thromboembolic complications occurred in 11 of 83 aneurysms treated with SAC, among which 3 occurred in 48 unruptured aneurysms (6.3%; p=0.046) and 8 occurred in 35 ruptured aneurysms (22.9%; p=0.046). However, there was no permanent morbidity due to thromboembolic complications in either group. Conclusion: The thromboembolic complication rate for SAC in patients with ruptured aneurysms was significantly higher than for those with unruptured aneurysms. However, there was no permanent morbidity of thromboembolic complications, there seems to be no reason to reluctant SAC due to the risk of thromboembolic complications in patients with SAH.
支架辅助盘绕术治疗颅内动脉瘤的血栓栓塞并发症:单中心经验
通讯作者:Yu Sam Won韩国成均馆大学医学院江北三星医院神经外科电话:+82-2-2001-2159传真:+82-2-2001-2157 E-mail: yusam.won@samsung.com目的:血栓栓塞是支架辅助卷取(SAC)手术中最常见的并发症。本研究旨在评估颅内动脉瘤SAC患者血栓栓塞并发症的发生率及危险因素。方法:2006年1月至2017年12月,对35例蛛网膜下腔出血(SAH)急性期患者(35个动脉瘤)行SAC治疗,未进行抗血小板预用药。此外,45例患者(48例未破裂动脉瘤)行SAC术前抗血小板药物治疗。比较未破裂和破裂动脉瘤组的基线患者特征。并分析血栓栓塞并发症的危险因素。结果:SAC治疗83例动脉瘤中11例发生血栓栓塞并发症,其中48例未破裂动脉瘤中3例发生血栓栓塞并发症(6.3%;P =0.046), 35例破裂动脉瘤中出现8例(22.9%;p = 0.046)。然而,两组患者均未出现因血栓栓塞并发症而导致的永久性发病。结论:动脉瘤破裂患者SAC血栓栓塞并发症发生率明显高于未破裂患者。然而,没有血栓栓塞并发症的永久性发病率,由于SAH患者血栓栓塞并发症的风险,似乎没有理由不愿意进行SAC。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信